Lazard Asset Management LLC Ionis Pharmaceuticals Inc Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 22,923 shares of IONS stock, worth $797,949. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,923
Previous 9,515 140.91%
Holding current value
$797,949
Previous $453,000 102.65%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$40.06 - $51.86 $537,124 - $695,338
13,408 Added 140.91%
22,923 $918,000
Q2 2024

Aug 14, 2024
BUY
$36.45 - $47.7 $60,507 - $79,182
1,660 Added 21.13%
9,515 $453,000
Q1 2024

May 14, 2024
BUY
$42.03 - $53.55 $51,024 - $65,009
1,214 Added 18.28%
7,855 $339,000
Q4 2023

Feb 14, 2024
BUY
$43.39 - $51.63 $3,644 - $4,336
84 Added 1.28%
6,641 $335,000
Q3 2023

Nov 14, 2023
BUY
$38.5 - $47.13 $54,670 - $66,924
1,420 Added 27.64%
6,557 $297,000
Q2 2023

Aug 14, 2023
SELL
$34.73 - $43.33 $36,501 - $45,539
-1,051 Reduced 16.98%
5,137 $210,000
Q1 2023

May 15, 2023
BUY
$33.58 - $41.2 $82,774 - $101,558
2,465 Added 66.21%
6,188 $220,000
Q4 2022

Feb 14, 2023
SELL
$37.12 - $46.52 $11,952 - $14,979
-322 Reduced 7.96%
3,723 $140,000
Q3 2022

Nov 14, 2022
SELL
$36.54 - $48.66 $57,733 - $76,882
-1,580 Reduced 28.09%
4,045 $178,000
Q2 2022

Aug 09, 2022
BUY
$31.71 - $43.0 $18,011 - $24,424
568 Added 11.23%
5,625 $207,000
Q1 2022

May 13, 2022
SELL
$29.88 - $37.04 $22,619 - $28,039
-757 Reduced 13.02%
5,057 $186,000
Q4 2021

Feb 09, 2022
BUY
$25.61 - $35.1 $116,627 - $159,845
4,554 Added 361.43%
5,814 $176,000
Q3 2021

Nov 15, 2021
SELL
$33.54 - $40.55 $21,163 - $25,587
-631 Reduced 33.37%
1,260 $42,000
Q2 2021

Aug 12, 2021
BUY
$34.54 - $47.25 $64,037 - $87,601
1,854 Added 5010.81%
1,891 $74,000
Q1 2021

May 14, 2021
SELL
$42.51 - $63.78 $85,402 - $128,134
-2,009 Reduced 98.19%
37 $1,000
Q4 2020

Feb 11, 2021
BUY
$45.3 - $60.27 $39,501 - $52,555
872 Added 74.28%
2,046 $115,000
Q3 2020

Nov 13, 2020
SELL
$47.45 - $62.95 $20,925 - $27,760
-441 Reduced 27.31%
1,174 $55,000
Q2 2020

Aug 13, 2020
SELL
$46.85 - $61.05 $47,974 - $62,515
-1,024 Reduced 38.8%
1,615 $95,000
Q1 2020

May 14, 2020
SELL
$41.6 - $63.4 $413,129 - $629,625
-9,931 Reduced 79.01%
2,639 $124,000
Q4 2019

Feb 13, 2020
SELL
$53.85 - $65.27 $2.02 Million - $2.44 Million
-37,430 Reduced 74.86%
12,570 $759,000
Q3 2016

Aug 07, 2019
BUY
N/A
50,000
50,000 $1.83 Million

Others Institutions Holding IONS

# of Institutions
403
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.94B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email